Collaboration is the core of who we are and what we do.

iTeos was founded on the principle that together we create breakthroughs for people living with cancer. Since its origins being spun out of the Ludwig Cancer Research and de Duve Institute, iTeos has operated under a single mantra, “Together We are Stronger.”

Tumor Immunology Collective

Translational Science Requires Deep Collaboration

We believe that digging deep into the science of tumor immunology can result in real breakthroughs for people living with cancer. We bring to each our collaborations our desire and drive to know more about the targets and the differentiated modalities we are researching. Through the Tumor Immunology Collective (TIC) we collaborate with like-minded organizations and scientists because together we can do more to bring the best possible treatment solutions to patients as we advance the field of tumor immunology.


Becoming Stronger Together: Academic Collaborators

Johns Hopkins University, Fred Hutch, Jules Bordet Instituut, Ludwig Cancer Research, VIB, UC Louvain, Oncode Institute

Becoming Stronger Together: Industry Collaborators

Glaxo Smith Kline, Bristol Meyers Squibb, Merck

Going Deep: Collaboration Opportunities

Deep relationships help us go deeper into science. If you or your organization believe that together we can do more for cancer patients, we’d like to hear from you. For more information on partnering with iTeos as part of the Tumor Immunology Collective, please reach out to us at [email protected]